Plasma exosomal miRNAs in persons with and without Alzheimer disease: Altered expression and prospects for biomarkers

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Lugli, Giovanni ^a   Cohen, Aaron M ^b   Bennett, David A ^c   Shah, Raj C ^c   Fields, Christopher J ^d   Hernandez, Alvaro G ^e   Smalheiser, Neil R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e High Performance Biological Computing Roy J Carver Biotechnology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 125B 5P; MICRORNA 138 5P; MICRORNA 139 5P; MICRORNA 141 3P; MICRORNA 150 5P; MICRORNA 152 3P; MICRORNA 185 5P; MICRORNA 23B 3P; MICRORNA 24 3P; MICRORNA 29B 3P; MICRORNA 3065 5P; MICRORNA 338 3P; MICRORNA 342 3P; MICRORNA 342 5P; MICRORNA 3613 3P; MICRORNA 3916; MICRORNA 4772 3P; MICRORNA 5001 3P; MICRORNA 548AT 5P; MICRORNA 659 5P; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CENTRIFUGATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DOWN REGULATION; EXOSOME; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYZER; GOLD STANDARD; HUMAN; HUMAN CELL; MACHINE LEARNING; MALE; MICRORNA BLOOD LEVEL; PILOT STUDY; PRACTICE GUIDELINE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; RNA SEQUENCE; ANIMAL; CASE CONTROL STUDY; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; MOUSE; PLASMA;

ALZHEIMER DISEASE; ANIMALS; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; EXOSOMES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MICE; MICRORNAS; PLASMA;

EID: 84947284577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139233     Document Type: Article

References (46)

1. Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, et al. Dominantly Inherited Alzheimer Network. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med. 2014 Mar 5; 6(226):226ra30. doi: 10.1126/scitranslmed.3007901 PMID: 24598588
2. Jack CR Jr, Holtzman DM. Biomarker modeling of Alzheimer's disease. Neuron. 2013 Dec 18; 80 (6):1347-58. doi: 10.1016/j.neuron.2013.12.003 PMID: 24360540
3. Bennett DA, Yu L, De Jager PL. Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease. Biochem Pharmacol. 2014 Apr 15; 88(4):617-30. doi: 10.1016/j.bcp.2014.01.037 PMID: 24508835
4. Absalon S, Kochanek DM, Raghavan V, Krichevsky AM. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci. 2013 Sep 11; 33(37):14645-59. doi: 10.1523/JNEUROSCI.1327-13.2013 PMID: 24027266
5. Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 2011 Feb; 121(2):193-205. doi: 10.1007/s00401-010-0756-0 PMID: 20936480
6. Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE, Zhou XJ. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One. 2010 Feb 1; 5(2):e8898. doi: 10.1371/journal.pone.0008898 PMID: 20126538
7. Hébert SS, Wang WX, Zhu Q, Nelson PT. A study of small RNAs from cerebral neocortex of pathologyverified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J Alzheimers Dis. 2013; 35(2):335-48. doi: 10.3233/JAD-122350 PMID: 23403535
8. Santa-Maria I, Alaniz ME, Renwick N, Cela C, Fulga TA, Van Vactor D, et al. Dysregulation of micro-RNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest. 2015 Feb; 125(2):681-6. doi: 10.1172/JCI78421 PMID: 25574843
9. Satoh J. Molecular network of microRNA targets in Alzheimer's disease brains. Exp Neurol. 2012 Jun; 235(2):436-46. doi: 10.1016/j.expneurol.2011.09.003 PMID: 21945006
10. Schipper HM, Maes OC, Chertkow HM, Wang E. MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio. 2007 Dec 20; 1:263-74. PMID: 19936094
11. Geekiyanage H, Jicha GA, Nelson PT, Chan C. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp Neurol. 2012 Jun; 235(2):491-6. doi: 10.1016/j.expneurol.2011.11.026 PMID: 22155483
12. Bekris LM, Lutz F, Montine TJ, Yu CE, Tsuang D, Peskind ER, et al. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma. Biomarkers. 2013 Aug; 18(5):455-66. doi: 10.3109/1354750X.2013.814073 PMID: 23822153
13. Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013 Jul 29; 14(7):R78. doi: 10.1186/gb-2013-14-7-r78 PMID: 23895045
14. Cheng L, Quek CY, Sun X, Bellingham SA, Hill AF. The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies. Front Genet. 2013 Aug 8; 4:150. doi: 10.3389/fgene.2013.00150 PMID: 23964286
15. Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, et al. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry. 2014 Oct 28.
16. Sheinerman KS, Umansky SR. Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci. 2013 Sep 10; 7:150. doi: 10.3389/fncel.2013.00150 PMID: 24058335
17. Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, et al. Circulating miR-125b as a biomarker of Alzheimer's disease. J Neurol Sci. 2014 Jan 15; 336(1-2):52-6. doi: 10.1016/j.jns.2013.10.002 PMID: 24139697
18. Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. J Alzheimers Dis. 2014; 39(2):253-9. doi: 10.3233/JAD-130932 PMID: 24157723
19. Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, et al. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J Alzheimers Dis. 2014; 40(4):1017-27. doi: 10.3233/JAD-132144 PMID: 24577456
20. Satoh J, Kino Y, Niida S. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data. Biomark Insights. 2015 Apr 15; 10:21-31. doi: 10.4137/BMI.S25132 (whole blood) PMID: 25922570
21. Wang T, Chen K, Li H, Dong S, Su N, Liu Y, et al. The feasibility of utilizing plasma miRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment. J Clin Psychiatry. 2015 Feb; 76(2):135-41. doi: 10.4088/JCP.13m08812 PMID: 25742200
22. Femminella GD, Ferrara N, Rengo G. The emerging role of microRNAs in Alzheimer's disease. Front Physiol. 2015 Feb 12; 6:40. doi: 10.3389/fphys.2015.00040 PMID: 25729367
23. Kim DH, Yeo SH, Park JM, Choi JY, Lee TH, Park SY, et al. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. Gene. 2014 Jul 25; 545(2):185-93. doi: 10.1016/j.gene.2014.05.031 PMID: 24838203
24. Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, et al. Circulating miRNA biomarkers for Alzheimer's disease. PLoS One. 2013 Jul 29; 8(7):e69807. doi: 10.1371/journal.pone. 0069807 PMID: 23922807
25. Liu Y, Zhang J, Han R, Liu H, Sun D, Liu X. Downregulation of serum brain specific microRNA is associated with inflammation and infarct volume in acute ischemic stroke. J Clin Neurosci. 2015 Feb; 22 (2):291-5. doi: 10.1016/j.jocn.2014.05.042 PMID: 25257664
26. Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, et al. Circulating miR-125b as a biomarker of Alzheimer's disease. J Neurol Sci. 2014 Jan 15; 336(1-2):52-6. doi: 10.1016/j.jns.2013.10.002 PMID: 24139697
27. Galimberti D, Villa C, Fenoglio C, Serpente M, Ghezzi L, Cioffi SM, et al. Circulating miRNAs as potential biomarkers in Alzheimer's disease. J Alzheimers Dis. 2014; 42(4):1261-7. doi: 10.3233/JAD-140756 PMID: 25024331
28. Villa C, Ridolfi E, Fenoglio C, Ghezzi L, Vimercati R, Clerici F, et al. Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease. J Alzheimers Dis. 2013; 35(3):487-94. doi: 10.3233/JAD-122263 PMID: 23435408
29. Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, et al. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol. 2014 Nov; 128(5):639-50. doi: 10.1007/s00401-014-1314-y PMID: 24997849
30. Hall DA, Bennett DA, Filley CM, Shah RC, Kluger B, Ouyang B, Berry-Kravis E. Fragile X gene expansions are not associated with dementia. Neurobiol Aging. 2014: 35:2637-2638. doi: 10.1016/j. neurobiolaging.2014.04.027 PMID: 24958193
31. Park M, Shah RC, Fogg LF, Wyatt JK. Daytime sleepiness in mild Alzheimer's disease with and without parkinsonian features. Sleep Med. 2011; 12:397-402. doi: 10.1016/j.sleep.2010.09.006 PMID: 21388877
32. Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, et al. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based study. Neuroepidemiology. 2006; 27:169-176. PMID: 17035694
33. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989; 39:1159-1169. PMID: 2771064
34. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56:1143-1153. PMID: 11342678
35. Lugli G, Larson J, Demars MP, Smalheiser NR. Primary microRNA precursor transcripts are localized at post-synaptic densities in adult mouse forebrain. J Neurochem. 2012 Nov; 123(4):459-66. doi: 10.1111/j.1471-4159.2012.07921.x PMID: 22897173
36. Smalheiser NR, Lugli G, Zhang H, Rizavi H, Cook EH, Dwivedi Y. Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS One. 2014 Jan 27; 9(1):e86469. doi: 10.1371/journal.pone.0086469 PMID: 24475125
37. Smalheiser NR, Lugli G, Rizavi HS, Torvik VI, Turecki G, Dwivedi Y. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One. 2012; 7(3): e33201. doi: 10.1371/journal.pone.0033201 PMID: 22427989
38. Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M, et al. Characterization of human plasmaderived exosomal RNAs by deep sequencing. BMC Genomics. 2013 May 10; 14:319. doi: 10.1186/1471-2164-14-319 PMID: 23663360
39. Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, et al. An anemia of Alzheimer's disease. Mol Psychiatry. 2014 Nov; 19(11):1227-34. doi: 10.1038/mp.2013.178 PMID: 24419041
40. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007 Jun 12; 8:166. PMID: 17565689
41. Schröder J, Ansaloni S, Schilling M, Liu T, Radke J, Jaedicke M, et al. MicroRNA-138 is a potential regulator of memory performance in humans. Front Hum Neurosci. 2014 Jul 11; 8:501. doi: 10.3389/fnhum.2014.00501 PMID: 25071529
42. Bicker S, Lackinger M, Weiß K, Schratt G. MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites. Cell Mol Life Sci. 2014 Oct; 71(20):3987-4005. doi: 10.1007/s00018-014-1671-7 PMID: 25008044
43. Wang X, Tan L, Lu Y, Peng J, Zhu Y, Zhang Y, Sun Z. MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha. FEBS Lett. 2015 Mar 12; 589(6):726-9. doi: 10.1016/j.febslet. 2015.02.001 PMID: 25680531
44. Somel M, Liu X, Tang L, Yan Z, Hu H, Guo S, et al MicroRNA-driven developmental remodeling in the brain distinguishes humans from other primates. PLoS Biol. 2011 Dec; 9(12):e1001214. doi: 10.1371/journal.pbio.1001214 PMID: 22162950
45. Bryniarski K, Ptak W, Martin E, Nazimek K, Szczepanik M, Sanak M, Askenase PW. Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells. PLoS One. 2015 Apr 29; 10(4):e0122991. doi: 10.1371/journal.pone.0122991 PMID: 25923429
46. Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, et al. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 2014 Aug 14. pii: S1552-5260(14)02469-8.